T 0431/96 (Monoclonal antibody/AGEN) of 23.02.1999
- European Case Law Identifier
- ECLI:EP:BA:1999:T043196.19990223
- Date of decision
- 23 February 1999
- Case number
- T 0431/96
- Petition for review of
- -
- Application number
- 84102916.8
- IPC class
- C12P 21/08
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- A method for the preparation of monoclonal antibody with specificity for crosslinked fibrin derivatives and an assay procedure using said antibody
- Applicant name
- Agen Biomedical Limited
- Opponent name
- Behringwerke Aktiengesellschaft
Innogenetics NV - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 1973European Patent Convention Art 83 1973
- Keywords
- Main request - sufficiency of disclosure (yes)
Inventive step (yes) - Catchword
- -
ORDER
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of the following documents:
(a) claims 1 to 16 for all designated contracting States except AT, and claims 1 to 16 for AT, submitted during oral proceedings as main request; and
(b) description as granted.